India Is One of the World’s Most Obese Countries, But Few Indians Want GLP 1s

Cheaper weight-loss drugs were expected to take off in India. But despite GLP-1s costing as little as $14 a month, demand has been slower than expected. From stigma to hesitant doctors, Satviki Sanjay explains why price isn’t the only barrier. ---------- Like this video? Subscribe https://www.youtube.com/@Bloomberg-News Bloomberg News is the first word in business news. Visit bloomberg.com for the latest on global business, markets and more. Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: https://www.bloomberg.com/subscriptions?in_source=YoutubeOriginals Bloomberg on YouTube: https://www.youtube.com/@business https://www.youtube.com/@markets https://www.youtube.com/@BloombergTechnology https://www.youtube.com/@BloombergPodcasts Connect with us on social: https://www.instagram.com/bloombergbusiness https://www.linkedin.com/company/bloomberg-news https://www.tiktok.com/@bloombergbusiness https://www.facebook.com/bloombergbusiness